Effects of WAON therapy on cognitive function and muscle strength in elderly heart failure patients

Effects of WAON therapy on cognitive function and muscle strength in elderly heart failure patients - Effects of WAON therapy on cognitive function and muscle strength in elderly heart failure patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037711

Enrollment

120

Registered

2019-08-19

Start date

2019-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart failure inpatient

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with heart failure who can obtain written informed consent from the person or family Patients with heart failure older than 65 years old when obtaining consent

Exclusion criteria

Exclusion criteria: Patients with a history of cerebrovascular disease or cerebrovascular dementia Patients with severe cognitive impairment and difficult to understand and implement Patients with acute myocardial infarction Patients with active bacterial infection Patients with severe hypertension Patients with severe anemia, purpura (those with bleeding factors)

Design outcomes

Primary

Measure	Time frame
Relative change (rate) in cerebral blood flow before and after WAON therapy 10-20 times	—

Secondary

Measure	Time frame
Evaluation of biomarkers, cognitive function, flail improvement effect before and after WAON therapy 10-20 times	—

Countries

Japan

Contacts

Public ContactShigeru Toyoda

Dokkyo Medical University Department of Cardiovascular Medicine

s-toyoda@dokkyomed.ac.jp0282-86-1111

Outcome results